Portrait of happy young black woman relaxing on wooden deck chair at tropical beach while looking at camera wearing spectacles. Smiling african american girl with fashion sunglasses enjoying vacation.

Zogenix, Inc. v. Apotex Inc. – Fintepla® (Fenfluramine HCl)

Start
Case Name: Zogenix, Inc. v. Apotex Inc., Civ. No. 21-1252-RGA, 2023 WL 5835828 (D. Del. Sept. 8, 2023) (Andrews, J.) – Drug Product and Patent(s)-in-Suit: Fintepla® (fenfluramine HCl); U.S. Patents Nos. 10,478,441 (“the ’441 patent”), 10,478,442 (“the ’442 patent”), and 11,406,606 (“the ’606 patent”)….
By: Robins Kaplan LLP
Previous Story

FTC Proposes Major Updates to Children’s Online Privacy Protection Act

Next Story

Key Considerations for Updating 2023 Annual Report Risk Factors